Elucidating the Innate Immunological Effects of Mild Magnetic Hyperthermia on U87 Human Glioblastoma Cells: An In Vitro Study

Cancer immunotherapies have been approved as standard second-line or in some cases even as first-line treatment for a wide range of cancers. However, immunotherapy has not shown clinically relevant success in glioblastoma (GBM). This is principally due to the brain’s “immune-privileged” status and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Persano, Stefano, Vicini, Francesco, Poggi, Alessandro, Fernandez, Jordi Leonardo Castrillo, Rizzo, Giusy Maria Rita, Gavilán, Helena, Silvestri, Niccolo, Pellegrino, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537446/
https://www.ncbi.nlm.nih.gov/pubmed/34683961
http://dx.doi.org/10.3390/pharmaceutics13101668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537446/
https://www.ncbi.nlm.nih.gov/pubmed/34683961
http://dx.doi.org/10.3390/pharmaceutics13101668

Ejemplares similares